CASE REPORT |
|
Year : 2021 | Volume
: 8
| Issue : 1 | Page : 25-28 |
|
A case of COVID-19 triggered Rhino-Orbital Pulmonary Mucormycosis in Central India
Chandra Pratap Singh Rathore1, Shirin Ansari2, Trupti Bajpai1
1 Department of Microbiology, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, Indore, Madhya Pradesh, India 2 Department of ENT, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, Indore, Madhya Pradesh, India
Correspondence Address:
Dr. Trupti Bajpai Department of Microbiology, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, MR-10, Ujjain-Indore Crossing, Sawner Road, Indore, Madhya Pradesh India
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/bmrj.bmrj_8_21
|
|
Mucormycosis is a rare but fatal, invasive opportunistic fungal infection generally described among immunocompromised individuals. The ongoing pandemic coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 has severely compromised the immune system of patients thereby making them vulnerable to mucormycosis, especially when they are lined up with associated comorbidities. Here, we present a case of one such 64-year-old male patient being on corticosteroids and a case of long-standing diabetes mellitus and chronic kidney disease. COVID-19 triggered the mucormycosis in this patient thereby leading to a condition we have described as rhino-orbital pulmonary mucormycosis.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|